Metformina Combix

Metformin Hydrochloride, the active ingredient in Metformina Combix, is a biguanide presented as an oral tablet for oral use. It is employed to improve glycemic control in adults with type 2 diabetes mellitus by decreasing hepatic glucose production and increasing peripheral insulin sensitivity.

GNH USA supplies Metformina Combix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams across global markets worldwide. The company adheres to stringent quality standards and provides regulatory support for import and distribution.

Metformina Combix (metformin hydrochloride) is used to manage hyperglycemia in the type 2 diabetes pathway and related metabolic conditions.

Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels. Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes when combined with lifestyle measures. Polycystic ovary syndrome: reduces insulin resistance and may improve ovulatory function in affected women.

Metformina Combix may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or flatulence - Diarrhea: loose stools, often transient - Metallic taste: altered taste perception - Decreased appetite: reduced food intake

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic disturbance - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis - Vitamin B12 deficiency: long‑term use may lead to hematologic abnormalities

When prescribing Metformina Combix, clinicians should consider several safety precautions to minimize risk.

Renal function assessment: evaluate eGFR before initiating and monitor periodically Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment Alcohol consumption: limit intake as it may increase acidosis risk Pregnancy and lactation: use only if potential benefits outweigh risks Drug interactions: review concomitant medications that affect renal clearance or increase lactic acidosis potential Store at ambient temperature: keep in original container, protect from moisture and heat

Metformina Combix can interact with other medicines, influencing its plasma concentration or the risk of adverse events.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure when combined with metformin - Cimetidine: can increase metformin plasma levels, raising lactic acidosis risk - Renally toxic drugs (e.g., aminoglycosides, NSAIDs): heighten risk of renal impairment

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia - Thiazide diuretics: can attenuate glucose‑lowering effect - ACE inhibitors or ARBs: require renal function monitoring - Alcohol: excessive intake raises lactic acidosis risk